Eli Lilly Builds $1.5 Billion Inventory Of Experimental Weight-Loss Pill As FDA Decision Looms - Eli Lilly and Co (NYSE:LLY), Novo Nordisk (NYSE:NVO)

Eli Lilly and Company (NYSE:LLY) has stockpiled $1.5 billion worth of inventory of its experimental oral weight-loss drug, orforglipron, according to a regulatory filing on Thursday.This significant inventory buildup is in anticipation of a decision by the U.S. Food and Drug Administration (FDA) expected in April. The inventory value has seen a substantial increase from last year’s nearly $550 million.The FDA has awarded the weight-loss pill a fast-track review voucher, potentially shortening the approval t ...